Sicheng Wu

Sicheng Wu

Auto-generated profile, based on publicly available information

Sicheng Wu

Guangdong Provincial Key Laboratory of Urology, Guangdong Engineering Research Center of Urinary Minimally invasive surgery Robot and Intelligent Equipment, Guangzhou Institute of Urology, Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510120, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2024 in Biomaterials Research
Verified
Journal Article
Open access
SWSicheng Wu
Sicheng Wu
GLGuanlin Li
Guanlin Li
WOWenrui Ouyang
Wenrui Ouyang
YTYuan Tian
Yuan Tian
SLShujue Li
Shujue Li
Hongxing LiuHongxing Liu
Hongxing Liu
It is urgent to develop an alternative dynamic therapy-based method to overcome the limited efficacy of traditional therapy methods for bladder cancer and the damage caused to patients. Sonodynamic therapy (SDT) has the advantages of high tissue penetration, high spatiotemporal selectivity, and being non-invasive, representing an emerging method for eradicating deep solid tumors. However, the effectiveness of SDT is often hindered by the inefficient production of reactive oxygen species and the nondegradability of the sonosensitizer. To improve the anti-tumor effect of SDT on bladder cancer, herein, a BP-based heterojunction sonosensitizer (BFeSe 2 ) was synthesized by anchoring FeSe 2 onto BP via P–Se bonding to enhance the stability and the effect of SDT. As a result, BFeSe 2 showed great cytotoxicity to bladder cancer cells under ultrasound (US) irradiation. BFeSe 2 led to a notable inhibition effect on tumor growth in subcutaneous tumor models and orthotopic tumor models under US irradiation. In addition, BFeSe 2 could also enhance T2-weighted magnetic resonance imaging (MRI) to achieve monitoring and guide treatment of bladder cancer. In general, BFeSe 2 sonosensitizer integrates MRI functions for precise treatment, promising great clinical potential for the theranostics of bladder cancer.

9 May 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
WOWenrui Ouyang
Wenrui Ouyang
HWHeng Wang
Heng Wang
ZZZhijian Zhao
Zhijian Zhao
MWMengting Wang
Mengting Wang
GLGuanlin Li
Guanlin Li
Hongxing LiuHongxing Liu
Hongxing Liu